Skip to main content
Premium Trial:

Request an Annual Quote

Broad Nabs $40M From NHLBI for Large-Scale Whole-Genome Sequencing Project

NEW YORK (GenomeWeb) – The Broad Institute today said that the National Heart, Lung, and Blood Institute has awarded it about $40 million to provide large-scale whole-genome sequencing to 20,000 individuals. 

The project is part of NHLBI's Trans-Omics for Precision Medicine (TOPMed) program and will be the first step toward a larger initiative to use whole-genome sequencing for discoveries in complex disease. Such discoveries, the Broad said, will serve as a resource to investigate factors that influence disease risk, identify disease subtypes, and develop more targeted and personalized treatments. 

In addition to sequencing the individuals, the Broad will provide data in support of small pilot projects in transcriptome sequencing and metabolite profiling. 

TOPMed supports the NHLBI's precision medicine initiative and couples whole-genome sequencing and other omics data with molecular, behavioral, imaging, environmental, and clinical data from studies focused on heart, lung, blood, and sleep disorders, according to NHLBI's website. 

Stacey Gabriel, senior director of the Broad Institute Genomics Platform, said that the Broad is well-suited to meet the challenges of the TOPMed program, as it has sequenced thousands of individuals from the Framingham Heart Study and patients with atrial fibrillation in the first phase of TOPMed. "Now we will be able to seamlessly scale to enable these new large projects to directly benefit studies in the genetics of disease," she said. 

The Broad added that it has significantly expanded its sequencing capabilities in order to meet increasing demand. The TOPMed project, along with other initiatives, will require the production of about 35,000 genomes during the next year, more than doubling the 14,375 genomes that it has completed during the past 12 months.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.